Petruzzi E, Bucalossi A, Corri S, Marsilii A, Di Noto C
Ric Clin Lab. 1983;13 Suppl 3:451-4.
The authors have investigated the effect of pentoxifylline administration (400 mg in three doses) in diabetic subjects with lower limb vasculopathy. The results have shown a marked improvement in clinical symptoms and VRBC and a slight improvement in fibrinogen and blood lipid levels.
